These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35020476)

  • 41. Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes.
    Sawyer A; Sobczak M; Forlenza GP; Alonso GT
    Diabetes Technol Ther; 2022 Jun; 24(6):409-415. PubMed ID: 35099306
    [No Abstract]   [Full Text] [Related]  

  • 42. Are all HCL systems the same? long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study.
    Santova A; Plachy L; Neuman V; Pavlikova M; Petruzelkova L; Konecna P; Venhacova P; Skvor J; Pomahacova R; Neumann D; Vosahlo J; Strnadel J; Kocourkova K; Obermannova B; Pruhova S; Cinek O; Sumnik Z
    Front Endocrinol (Lausanne); 2023; 14():1283181. PubMed ID: 37908748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes.
    Piccini B; Pessina B; Casalini E; Lenzi L; Toni S
    Pediatr Diabetes; 2022 Dec; 23(8):1647-1655. PubMed ID: 36317539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.
    Sherr JL; Buckingham BA; Forlenza GP; Galderisi A; Ekhlaspour L; Wadwa RP; Carria L; Hsu L; Berget C; Peyser TA; Lee JB; O'Connor J; Dumais B; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2020 Mar; 22(3):174-184. PubMed ID: 31596130
    [No Abstract]   [Full Text] [Related]  

  • 45. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.
    Zhou K; Isaacs D
    Curr Cardiol Rep; 2022 Sep; 24(9):1159-1167. PubMed ID: 35727409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lower Daily Carbohydrate Intake Is Associated With Improved Glycemic Control in Adults With Type 1 Diabetes Using a Hybrid Closed-Loop System.
    Lehmann V; Zueger T; Zeder A; Scott S; Bally L; Laimer M; Stettler C
    Diabetes Care; 2020 Dec; 43(12):3102-3105. PubMed ID: 32998989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Control-IQ Technology in a General Endocrine Clinic.
    Usoh CO; Price C; Johnson CP; Speiser JL; Aloi JA
    Endocr Pract; 2023 Jan; 29(1):29-32. PubMed ID: 36280026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study.
    Paldus B; Lee MH; Jones HM; McAuley SA; Horsburgh JC; Roem KL; Ward GM; MacIsaac RJ; Cohen N; Colman PG; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Jan; 21(1):56-58. PubMed ID: 30620641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives.
    Hood KK; Laffel LM; Danne T; Nimri R; Weinzimer SA; Sibayan J; Bailey RJ; Schatz D; Bratina N; Bello R; Punel A; Calhoun P; Beck RW; Bergenstal RM; Phillip M
    Diabetes Technol Ther; 2021 Dec; 23(12):857-861. PubMed ID: 34270328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.
    Sherwood JS; Castellanos LE; O'Connor MY; Balliro CA; Hillard MA; Gaston SG; Bartholomew R; Greaux E; Sabean A; Zheng H; Marchetti P; Uluer A; Sawicki GS; Neuringer I; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
    Diabetes Care; 2024 Jan; 47(1):101-108. PubMed ID: 37874987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study.
    Lee MH; Vogrin S; Paldus B; Jones HM; Obeyesekere V; Sims C; Wyatt SA; Ward GM; McAuley SA; MacIsaac RJ; Krishnamurthy B; Sundararajan V; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Sep; 21(9):499-506. PubMed ID: 31264889
    [No Abstract]   [Full Text] [Related]  

  • 52. Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations.
    Forlenza GP; Carlson AL; Galindo RJ; Kruger DF; Levy CJ; McGill JB; Umpierrez G; Aleppo G
    Diabetes Technol Ther; 2022 Nov; 24(11):814-823. PubMed ID: 35763323
    [No Abstract]   [Full Text] [Related]  

  • 53. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial.
    Bergenstal RM; Nimri R; Beck RW; Criego A; Laffel L; Schatz D; Battelino T; Danne T; Weinzimer SA; Sibayan J; Johnson ML; Bailey RJ; Calhoun P; Carlson A; Isganaitis E; Bello R; Albanese-O'Neill A; Dovc K; Biester T; Weyman K; Hood K; Phillip M;
    Lancet; 2021 Jan; 397(10270):208-219. PubMed ID: 33453783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes.
    Boscari F; Ferretto S; Cavallin F; Bruttomesso D
    Diabetes Res Clin Pract; 2022 Mar; 185():109784. PubMed ID: 35183648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study.
    Sherwood JS; Jafri RZ; Balliro CA; Zheng H; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
    J Cyst Fibros; 2020 Jan; 19(1):159-161. PubMed ID: 31420176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system.
    Berget C; Messer LH; Vigers T; Frohnert BI; Pyle L; Wadwa RP; Driscoll KA; Forlenza GP
    Pediatr Diabetes; 2020 Mar; 21(2):310-318. PubMed ID: 31837064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?
    Scheuing N; Badenhoop K; Borkenstein M; Konrad K; Lilienthal E; Laubner K; Naeke A; Rami-Merhar B; Thon A; Wiemann D; Holl RW;
    Pediatr Diabetes; 2015 Feb; 16(1):10-5. PubMed ID: 24984902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
    McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
    BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.